The Effect of Moderate Weight Loss on a Non-Invasive Biomarker of Liver Fibrosis: A Randomised Controlled Trial

<b><i>Background:</i></b> Referral to weight loss programmes is the only effective treatment for non-alcoholic fatty liver disease (NAFLD). Clinicians should advise weight loss and screen for liver fibrosis using the Enhanced Liver Fibrosis (ELF) score. <b><i>Aim:</i></b> To examine if the ELF score changes with weight loss. <b><i>Design and Setting:</i></b> Randomised...